Loading...
The Clorox Company
CLX•NYSE
Consumer DefensiveHousehold & Personal Products
$127.31
$-2.34(-1.80%)
The Clorox Company (CLX) Financial Performance & Statements
Review The Clorox Company’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-4.01%
↓ 4.006%
Operating Income Growth
-25.16%
↓ 25.16%
Net Income Growth
87.92%
↑ 87.92%
Operating Cash Flow Growth
-39.98%
↓ 39.98%
Operating Margin
18.45%
↑ 18.45%
Gross Margin
45.13%
↑ 45.13%
Net Profit Margin
9.89%
↑ 9.89%
ROE
742.25%
↑ 742.25%
ROIC
38.58%
↑ 38.58%
The Clorox Company (CLX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for The Clorox Company stock.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $1.69B | $1.76B | $1.90B | $1.81B |
| Cost of Revenue | $948.00M | $955.00M | $1.02B | $1.05B |
| Gross Profit | $738.00M | $807.00M | $879.00M | $766.00M |
| Gross Profit Ratio | $0.44 | $0.46 | $0.46 | $0.42 |
| R&D Expenses | $31.00M | $31.00M | $33.00M | $32.00M |
| SG&A Expenses | $471.00M | $482.00M | $526.00M | $516.00M |
| Operating Expenses | $507.00M | $513.00M | $559.00M | $548.00M |
| Total Costs & Expenses | $1.26B | $1.47B | $1.58B | $1.60B |
| Interest Income | $2.00M | $0.00 | $23.00M | $1.00M |
| Interest Expense | $22.00M | $21.00M | $21.00M | $22.00M |
| Depreciation & Amortization | $53.00M | $54.00M | $59.00M | $58.00M |
| EBITDA | $315.00M | $255.00M | $358.00M | $42.00M |
| EBITDA Ratio | $0.19 | $0.14 | $0.19 | $0.02 |
| Operating Income | $231.00M | $294.00M | $320.00M | $234.00M |
| Operating Income Ratio | $0.14 | $0.17 | $0.17 | $0.13 |
| Other Income/Expenses (Net) | $6.00M | -$117.00M | -$45.00M | -$276.00M |
| Income Before Tax | $237.00M | $177.00M | $275.00M | -$42.00M |
| Income Before Tax Ratio | $0.14 | $0.10 | $0.14 | -$0.02 |
| Income Tax Expense | $43.00M | $74.00M | $54.00M | $8.00M |
| Net Income | $193.00M | $99.00M | $216.00M | -$51.00M |
| Net Income Ratio | $0.11 | $0.06 | $0.11 | -$0.03 |
| EPS | $1.55 | $0.80 | $1.74 | -$0.41 |
| Diluted EPS | $1.54 | $0.79 | $1.73 | -$0.41 |
| Weighted Avg Shares Outstanding | $123.77M | $123.80M | $124.30M | $124.25M |
| Weighted Avg Shares Outstanding (Diluted) | $124.66M | $124.68M | $125.05M | $124.25M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan